These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8099168)

  • 21. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy.
    Hamon P; Bovier-Lapierre M; Robert M; Peynaud D; Pugeat M; Orgiazzi J
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1089-93. PubMed ID: 3182960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [D-thyroxin in the therapy of type IIa and IIb hyperlipoproteinemias].
    Hempel RD; Müller G; Burchardt U
    Z Gesamte Inn Med; 1977 Jun; 32(11):suppl 175-6. PubMed ID: 201111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of D-thyroxine to increase fetal hemoglobin levels in normal and anemic baboons.
    Koeller D; DeSimone J; Heller P
    Blood Cells; 1982; 8(1):187-91. PubMed ID: 6180786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug treatment of hypercholesterolemia. Experience with a combination of dextrothyroxine and betapyridylcarbinol (author's transel)].
    Schneider J; Schubotz R; Manteuffel Ev; Kaffarnik H
    Med Klin; 1978 Jun; 73(23):874-7. PubMed ID: 661731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of dextro-thyroxine (choloxin) in cardiovascular disease. Report of a clinical study.
    Reinhardt DJ
    Del Med J; 1968 Mar; 40(3):63-7. PubMed ID: 4868744
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics].
    Martinelli M; Albini U; Villecco A
    Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
    Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
    J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prolonged application of thyroid derivatives in patients with hypercholesterolemia. II. Experiences with dextrothyroxine].
    Reisel JH
    Ned Tijdschr Geneeskd; 1965 Dec; 109(50):2391-5. PubMed ID: 5322029
    [No Abstract]   [Full Text] [Related]  

  • 30. Sodium dextrothyroxine as a hypocholesterolemic agent: retrospective analysis of 6000 patients.
    Williams W; Warner W
    Manit Med Rev; 1968 Oct; 48(8):374-6. PubMed ID: 5724155
    [No Abstract]   [Full Text] [Related]  

  • 31. The therapy of hypercholesterolemia and six years' use of sodium dextrothyroxine: progress note.
    Cohen BM
    Curr Ther Res Clin Exp; 1967 Dec; 9(12):618-22. PubMed ID: 4965457
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical experience with dextrothyroxine in hypercholesterolemia.
    Owen WR
    Manit Med Rev; 1968 Oct; 48(8):370-3. PubMed ID: 5724154
    [No Abstract]   [Full Text] [Related]  

  • 33. Dextrothyroxine with propranolol in treatment of hypercholesterolaemia.
    Krikler DM; Lefevre D; Lewis B
    Lancet; 1971 May; 1(7706):934-6. PubMed ID: 4102268
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of sodium dextrothyroxine on serum cholesterol and mortality rates in cardiac patients.
    Bernstein A; Simon F; Schmitz TH; Warner WL
    Angiology; 1973 Apr; 24(4):205-11. PubMed ID: 4699516
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of glycogenosis type III with total parenteral nutrition, continuous intragastric infusion and D-thyroxine].
    Böhles H; Dick W; Scharf J
    Infusionsther Klin Ernahr; 1982 Aug; 9(4):160-1. PubMed ID: 6813261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of diet changes and use of dextrothyroxine and chlorphenisate on serum lipids].
    Arteaga A; Cisternas H; Torres MC; Alliende ME
    Rev Med Chil; 1969 May; 97(5):285-90. PubMed ID: 5386042
    [No Abstract]   [Full Text] [Related]  

  • 37. Dextrothyroxine treatment of phosphorylase-kinase deficiency glycogenosis in four boys.
    Garibaldi LR; Borrone C; de Martini I; Battistini E
    Helv Paediatr Acta; 1978 Nov; 33(4-5):435-41. PubMed ID: 280544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical use of dextrothyroxine in hypercholesterolemic states. An eight-year appraisal.
    Cohen BM
    J Clin Pharmacol J New Drugs; 1969; 9(1):45-56. PubMed ID: 5250312
    [No Abstract]   [Full Text] [Related]  

  • 40. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.